换一批
换一批Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.
第一作者：
Philippe,Moreau
第一单位：
Hematology Department, University Hospital Hôtel-Dieu, Nantes, France. Electronic address: philippe.moreau@chu-nantes.fr.
作者：
Philippe,Moreau [1]
;
Cyrille,Hulin [2]
;
Aurore,Perrot [3]
;
Bertrand,Arnulf [4]
;
Karim,Belhadj [5]
;
Lotfi,Benboubker [6]
;
Sonja,Zweegman [7]
;
Hélène,Caillon [8]
;
Denis,Caillot [9]
;
Hervé,Avet-Loiseau [10]
;
Michel,Delforge [11]
;
Thomas,Dejoie [8]
;
Thierry,Facon [12]
;
Cécile,Sonntag [13]
;
Jean,Fontan [14]
;
Mohamad,Mohty [15]
;
Kon-Siong,Jie [16]
;
Lionel,Karlin [17]
;
Frédérique,Kuhnowski [18]
;
Jérôme,Lambert [19]
;
Xavier,Leleu [20]
;
Margaret,Macro [21]
;
Frédérique,Orsini-Piocelle [22]
;
Murielle,Roussel [23]
;
Jean Marc,Schiano de Colella [24]
;
Niels Wcj,van de Donk [7]
;
Soraya,Wuillème [25]
;
Annemiek,Broijl [26]
;
Cyrille,Touzeau [27]
;
Mourad,Tiab [28]
;
Jean-Pierre,Marolleau [29]
;
Nathalie,Meuleman [30]
;
Marie-Christiane,Vekemans [31]
;
Matthijs,Westerman [32]
;
Saskia K,Klein [33]
;
Mark-David,Levin [34]
;
Fritz,Offner [35]
;
Martine,Escoffre-Barbe [36]
;
Jean-Richard,Eveillard [37]
;
Réda,Garidi [38]
;
Winnie,Hua [39]
;
Jianping,Wang [40]
;
Alba,Tuozzo [40]
;
Carla,de Boer [41]
;
Melissa,Rowe [42]
;
Veronique,Vanquickelberghe [43]
;
Robin,Carson [40]
;
Jessica,Vermeulen [41]
;
Jill,Corre [10]
;
Pieter,Sonneveld [26]
;
Intergroupe Francophone du Myélome, the Dutch-Belgian Cooperative Trial Group for Hematology Oncology and the CASSIOPEIA Investigators
作者单位：
Hematology Department, University Hospital Hôtel-Dieu, Nantes, France. Electronic address: philippe.moreau@chu-nantes.fr.
[1]
Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.
[2]
Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, Université de Toulouse, Toulouse, France.
[3]
Immuno-hématologie, Hôpital Saint Louis, APHP, Université Paris Cité, Paris, France.
[4]
Unité Fonctionnelle Hémopathies Lymphoïdes, Centre Hospitalier Universitaire Henri Mondor, Creteil, France.
[5]
Hôpital de Bretonneau, Centre Hospitalier Régional Universitaire de Tours, Tours, France.
[6]
Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
[7]
Biochemistry Laboratory, Nantes University Hospital, Nantes, France.
[8]
Service d'Hematologie, Institut de Cancérologie de Bourgogne, Dijon, France.
[9]
Unité de Genomique du Myélome, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, Université de Toulouse, Toulouse, France.
[10]
University of Leuven, Leuven, Belgium.
[11]
University of Lille, Centre Hospitalier Universitaire Lille, Service des Maladies du Sang, Lille, France.
[12]
University Hospital, Hôpital Hautepierre, Strasbourg, France.
[13]
University Hospital Jean Minjoz, Besancon, France.
[14]
Hematology and Cellular Therapy Department of Saint-Antoine Hospital, Sorbonne University, Paris, France.
[15]
Department of Internal Medicine, Zuyderland MC, Sittard, Netherlands.
[16]
Lyon University Hospital, Hematology Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
[17]
Institut Curie Paris, Paris, France.
[18]
Hôpital Saint-Louis, Paris, France.
[19]
University of Poitiers, Centre Hospitalier Universitaire and Inserm 1313, Poitiers, France.
[20]
Centre Hospitalier Universitaire de Caen, Caen, France.
[21]
Centre Hospitalier Annecy Genevois, Pringy, France.
[22]
Centre Hospitalier Universitaire Dupuytren, Limoges, France.
[23]
Institut Paoli-Calmettes, Marseille, France.
[24]
Hematology Biology, Nantes University Hospital, Nantes, France.
[25]
Department of Hematology, EMN/Erasmus MC Cancer Institute, Rotterdam, Netherlands.
[26]
Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
[27]
Centre Hospitalier Départemental Vendée, La Roche sur Yon, France.
[28]
Hematology Clinic, Amiens University Hospital, Amiens, France.
[29]
Department of Hematology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
[30]
Université Catholique de Louvain, Cliniques universitaires Saint-Luc, Brussels, Belgium.
[31]
Northwest Clinics, Alkmaar, Netherlands.
[32]
Department of Hematology, University Medical Center Groningen, Groningen, Netherlands.
[33]
Department of Internal Medicine, Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands.
[34]
University Hospital Ghent, Ghent, Belgium.
[35]
Rennes University Hospital, Hôpital de Pontchaillou, Rennes, France.
[36]
Brest University Hospital, Hôpital A Morvan, Brest, France.
[37]
Saint-Quentin Hospital Center, Saint Quentin, France.
[38]
Cytel, Waltham, MA, USA.
[39]
Janssen Research & Development, Spring House, PA, USA.
[40]
Janssen Research & Development, Leiden, Netherlands.
[41]
Janssen Research & Development, High Wycombe, UK.
[42]
Janssen Research & Development, Beerse, Belgium.
[43]
主题词
人类(Humans);多发性骨髓瘤(Multiple Myeloma);地塞米松(Dexamethasone);中年人(Middle Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);抗体, 单克隆(Antibodies, Monoclonal);女(雌)性(Female);男(雄)性(Male);成年人(Adult);老年人(Aged);沙立度胺(Thalidomide);随访研究(Follow-Up Studies);青少年(Adolescent);青年人(Young Adult)
DOI
10.1016/S1470-2045(24)00282-1
PMID
38889735
发布时间
2025-01-24
- 浏览0
The Lancet. Oncology
The Lancet. Oncology
1003-1014页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
